Showing results (1481-1490 of 1,955) with videos related to

Sort By:
Pageof 196
American Heart Journal|September 11, 2013
Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialDavid A Garcia, Lars Wallentin, Renato D Lopes, et al.
BMJ Open|November 16, 2020
Vascular and metabolic risk factor differences prior to dementia diagnosis: a multidatabase case-control study using European electronic health recordsGayan Perera, P R Rijnbeek, Myriam Alexander, et al.
The Annals of Pharmacotherapy|June 19, 2008
Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation ForumDavid A Garcia, Daniel M Witt, Elaine Hylek, et al.
American Heart Journal|June 20, 2017
Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)Benjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
Leukemia|May 25, 2011
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphomaR A Wilcox, K Ristow, T M Habermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphomaJacob P Smeltzer, Jason M Jones, Steven C Ziesmer, et al.
Cytokine|September 27, 2012
Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control studyBridget Charbonneau, Matthew J Maurer, Stephen M Ansell, et al.
American Heart Journal|June 12, 2020
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)Larry R Jackson, Sunghee Kim, Rosalia Blanco, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2016
Immunologic Autograft Engineering and Survival in Non-Hodgkin LymphomaLuis F Porrata, Edwin A Burgstaler, Jeffrey L Winters, et al.
Molecular Cancer Therapeutics|March 5, 2020
Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid TumorsJohn H Strickler, Patricia LoRusso, Ravi Salgia, et al.
Pageof 196